Indo Rama Synthetics (India) Limited (INDORAMA)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 total income grew 10% y-y to INR1,344 Cr; EBITDA rose 46.4% to INR117.7 Cr; PAT up 201.8% to INR74.1 Cr
- H1 FY27 EBITDA margin expanded to 9.9% from 7.1%; PAT margin improved to 6% from 3.1%
- Net debt reduced 23.5% to INR852 Cr; debt-to-equity improved to 1.31x; ROE at 38.2%, ROCE 27%
- INR200 Cr specialty filament and fiber expansion planned, targeting 15% revenue and 20% EBITDA growth with <2 years payback
- Domestic PTA capacity additions expected to reduce import dependence and improve margins by 2-3%
- EBITDA margins of ~9.9% maintained last 6 months; management expects double-digit margins in FY28-FY29
- Capacity utilization: PET chip plant at 60%, filament and fiber at 100%; volume expected to rebound to 475k tonnes next year
- Export share fell to 6% from 20-25% due to raw material sourcing; expected to rise with India-UK/EU/US trade agreements
- Specialty products to include cationic, dope dyed, colored yarns; fiber line restart planned for specialty fibers
- No plans to enter fabric/weaving; sourcing synergy with sister companies for spandex raw materials
- Management confident of sustainable profitability due to anti-dumping duty withdrawal, improved domestic raw material availability, and textile export growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDORAMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDORAMA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indo Rama Synthetics (India) Limited
Important.
The summary above is generated automatically from Indo Rama Synthetics (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.